Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Janel (JANL) Cash & Equivalents (2016 - 2026)

Janel has reported Cash & Equivalents over the past 16 years, most recently at $6.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 185.83% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.7 million, up 185.83%, while the annual FY2025 figure was $11.0 million, 255.68% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $6.7 million at Janel, down from $11.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $11.0 million in Q3 2025 and troughed at $1.6 million in Q4 2023.
  • A 5-year average of $4.0 million and a median of $3.3 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 62.66% in 2023 and later surged 255.68% in 2025.
  • Year by year, Cash & Equivalents stood at $5.2 million in 2021, then fell by 19.88% to $4.2 million in 2022, then plummeted by 62.0% to $1.6 million in 2023, then surged by 48.83% to $2.4 million in 2024, then surged by 185.83% to $6.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for JANL at $6.7 million in Q4 2025, $11.0 million in Q3 2025, and $3.9 million in Q2 2025.